Our governance structure has been established to address the evolving genomic landscape, and to reflect the broad portfolio of genomic technologies in health.
The governance model enables consultation with a wide range of stakeholders, from consumers and the community, through to industry, government, and international genomic endeavours.
Independent Advisory Board
Chaired by Prof Brian Schmidt, Vice Chancellor and President of The Australian National University, our Independent Advisory Board advises on Australian Genomics activity and facilitates the implementation and uptake of Australian Genomics outcomes in consideration of industry, healthcare, academia and government policy.
View committee
- Prof Brian Schmidt AC (Chair), Australian National University
- John Brumby AO, La Trobe University
- Dame Quentin Bryce AD, CVO, 25th Governor General of Australia
- Prof Tom Calma AO, Poche Indigenous Health Network
- Prof Ian Frazer AC, University of Queensland
- Jane Halton AO PSM, COTA Australia
- Penny Shakespeare, Department of Health and Aged Care
- Peter Yates AM, AIA Australia Limited, Linfox Australia Pty Ltd
National Steering Committee
Our National Steering Committee is made up of the leads of our Grant Program, each applying their expertise across the research priorities of Australian Genomics. With shared national leadership, the committee monitors the progress of our work and drives the scientific strategy, engagement, coordination and coherence of Australian Genomics.
View committee
- Prof Kathryn North, Murdoch Children’s Research Institute (Chair)
- Tiffany Boughtwood, Australian Genomics
- A/Prof Yemima Berman, Royal North Shore Hospital / Human Genetics Society of Australasia
- Prof Alex Brown, Australian National University / Telethon Kids Institute
- Kathy Campbell, Industry Genomic Network Alliance
- Prof John Christodoulou, Murdoch Children’s Research Institute
- Prof Sally Dunwoodie, Victor Chang Cardiac Research Institute
- Prof Clara Gaff, Melbourne Genomics Health Alliance
- A/Prof Ilias Goranitis, University of Melbourne
- Prof Oliver Hofmann, The University of Melbourne Centre for Cancer Research
- Dorothy Keefe, Cancer Australia
- Louise Lyons, Telethon Kids Institute
- Prof Julie McGaughran, Genetic Health Queensland
- Sean Murray, Mito Foundation
- Prof Ainsley Newson, The University of Sydney
- Dr Kristen Nowak, University of Western Australia / WA Health, Government of Western Australia
- Prof Hamish Scott, SA Pathology
- Prof Amanda Spurdle, QIMR Berghofer Medical Research Institute
- Prof Zornitza Stark, Victorian Clinical Genetics Services
- A/Prof Vanessa Tyrrell, Children’s Cancer Institute / Zero Children’s Cancer
- Prof Robyn Ward, The University of Sydney
National Implementation Committee
The National Implementation Committee provides guidance to Australian Genomics on its 2024-2025 Grant Program. It brings together expert researchers, clinicians and service providers, Commonwealth, state and territory governments. It is a forum to support communication of genomic research outcomes; share government priorities to guide research strategy; and inform genomic health policy development and implementation. Australian Genomics shares its progress toward the objectives of its research program, and the committee deliberates about objectives that may be considered from a policy and prioritisation perspective by the Health Technology and Genomics Collaboration.
View committee
- Prof Kathryn North, Murdoch Children’s Research Institute (Chair)
- Prof Christopher Barnett, SA Health
- Clare Donovan, Department of Health and Aged Care
- Marianne Griffin, Department of Health Victoria
- Celia Halliburton, NSW Ministry of Health
- Jodi Hallas, Queensland Health
- Renaye Lucchese, Department of Health and Aged Care
- Dimitrios Menouhos, NT Health
- Dr Kristen Nowak, WA Health, Government of Western Australia
- Dr Suthanthira Ramamoorthy, NT Health
- Dr Jade Redfern, ACT Health
- Penny Shakespeare, Department of Health and Aged Care
- Dr Mathew Wallis, Tasmanian Health Service
- Prof Robyn Ward, Medical Services Advisory Committee
- Tiffany Boughtwood, Australian Genomics
- Prof John Christodoulou, Murdoch Children’s Research Institute
- Mathilde Desselle, Queensland Health
- Prof Clara Gaff, Melbourne Genomics Health Alliance
- Prof Zornitza Stark, Victorian Clinical Genetics Services
- Julie White, Queensland Health
International Advisors
The advisors bring international best practice to our work and provide opportunities for international collaboration. They include representatives of the Global Alliance for Genomics and Health (GA4GH), the GA4GH Genomics in Health Implementation Forum, the Global Genomic Medicine Collaborative (G2MC), Genomics England, GEM Japan, Broad Institute, Canadian Institute of Health Research and H3Africa Bionet.
Community Advisory Group
The Community Advisory Group brings together experienced patient advocates providing counsel on our research activity. The Group advises on the design and language of patient surveys, digital health and data management strategy, and ethical, legal and social analyses of genomics.
View committee
- Sean Murray, Mito Foundation (Chair)
- Johanna Barclay, Australian Alliance for Indigenous Genomics
- Jessica Bean, Patient advocate
- Rachael Casella, Patient advocate
- Christine Cockburn, Rare Cancers Australia
- Kris Pierce, SCN2A Australia
- Julie Rae, Breast Cancer Network of Australia
- Robyn Smith, Inherited Cancers Australia
- Spase Veljanovski, Centre for Culture, Ethnicity & Health
- Tiffany Boughtwood, Australian Genomics
- Prof John Christodoulou, Murdoch Children’s Research Institute
Aboriginal and Torres Strait Islander Advisory Group
The Aboriginal and Torres Strait Islander peoples genomic advisory group was formed by the Australian Government’s Department of Health. Committee members identify key issues impacting health access for Aboriginal and Torres Strait Islander peoples and research in terms of the clinical application of genomics. The Group will provide Australian Genomics with advice on its research priorities and engagement of the community.
Industry Advisory Group
The Industry Genomics Network Alliance (InGeNA) was formed in late 2020 to strengthen collaboration, coordinate on key issues and realise opportunities for all Australians to benefit from precision healthcare. The companies who founded InGeNA under the auspices of the Australasian Institute of Digital Health will collaborate on programs to embed genomics across Australian healthcare. Companies representing pathology, technology and biopharma sectors, contributed funding to start InGeNA matched by MTPConnect’s Industry Growth Centre Project Fund Program.